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Introduction {#s1}
============

Protists of the genus *Crithidia* (Léger, 1902) (Kinetoplastida: Trypanosomatidae) are flagellate parasites that exclusively infect insects [@pone.0113837-Wallace1]. The numerous species of *Crithidia* have broad host specificity and are able to parasitize a variety of species grouped into the orders Diptera, Hemiptera and Himenoptera. Specificity also varies importantly depending on the species of the parasite [@pone.0113837-Wallace1]. Particularly, *C. fasciculata* successfully infects many species of mosquitoes.

Although these parasites are polymorphic, two stages are clearly distinguished. Choanomastigotes are free-swimming stumpy cells characteristic of this genus that are round in their posterior part and truncated in the apical pole by the funnel-shaped flagellar pocket close to the kinetoplast, which is slightly anterior to the nucleus. Amastigotes are non-motile round cells with a flagellum non-emergent from the cellular body. Therefore, they are morphologically similar to amastigotes of the genus *Leishmania*, although they are extracellular (reviewed in [@pone.0113837-Olsen1]). The life cycle of *C. fasciculata* is developed in the gut of the culicid, which becomes infected by ingestion of amastigotes voided with feces of other hosts. Then, amastigotes undergo a differentiation process into choanomastigotes to ensure proper colonization of the gut. Choanomastigotes differentiate back into non-motile round amastigotes that are attached to the gut epithelium by hemidesmosomes [@pone.0113837-Ibrahim1] frequently leading to damage [@pone.0113837-Schaub1]. Infected adult mosquitoes contaminate aquatic environments with amastigotes as well as flowers when they feed on nectar, thus providing chances for transmission of the parasite. Amastigotes are released within the feces or the entire body of the dead insect. Eventually, the larval and pupal instars of mosquitoes get infected in the aquatic habitat and finally amastigotes are transmitted to the adult mosquito through the metamorphosing gut [@pone.0113837-Olsen1] leading to completion of the life cycle ([Fig. 1A](#pone-0113837-g001){ref-type="fig"}).

![Life cycle, growth kinetics and peanut lectin agglutination of *C. fasciculata* choanomastigotes.\
(A) The monogenetic life cycle of *C. fasciculata* involves a culicid host, where amastigotes attached to the gut epithelium and voided in faeces are disseminated in the environment and orally passed to other hosts at any of the developmental stages. Choanomastigotes are the motile stage that allows the colonization of the gut of the host. GE: gut epithelium. Adapted from Olsen, 1974. (B) Average growth curve of three *C. fasciculata* choanomastigote cultures (three biological replicates). Total proteins were extracted every day until the culture reached the stationary phase. N is the average cell density. (C) and (D) 10% Giemsa staining of the PNA^+^ and PNA^-^ *C. fasciculata* choanomastigote subpopulations within the stationary phase of axenic culture, respectively.](pone.0113837.g001){#pone-0113837-g001}

Parasites grouped into the genus *Crithidia* develop monogenetic life cycles involving the extracellular choanomastigote and amastigote stages, and consequently do not infect mammals. The comparison with species of the same family developing digenetic life cycles responsible for leishmaniasis and trypanosomiasis is of outstanding interest. Even though these parasites afflict millions of people worldwide, they are still neglected [@pone.0113837-WHO1]. As a difference with *Leishmania* spp., parasites from the genus *Crithidia* are not pathogenic to humans. For this reason, their biology at the molecular and cellular levels remains almost unexplored despite their evolutionary relation with the genus *Leishmania* (reviewed in [@pone.0113837-Stevens1]). Advantageously, both organisms are closely related at the crown of the phylogenetic tree of trypanosomatids [@pone.0113837-Stevens1], [@pone.0113837-Vickerman1], [@pone.0113837-Maslov1], [@pone.0113837-Hughes1] despite their different life cycles.

There has been no attempt to quantify differential transcript and protein abundance at medium or large scale in any of the *Crithidia* species so far. The comparison between monogenetic and digenetic trypanosomatids may contribute to explain the mechanisms of adaptation to different hosts in the latter, which are mammals in the case of *Leishmania* spp. and *Trypanosoma* spp. This study is, to our knowledge, the first insight into the proteome of *C. fasciculata* choanomastigotes in axenic culture and has been performed by two dimension electrophoresis (2DE)-based analysis and protein identification by MALDI-TOF/TOF tandem mass spectrometry. The recent release of the *C. fasciculata* genome sequence and annotations has led to successful identification of most of the spots analyzed. Agglutination of choanomastigotes with PNA has been tested with positive results and a proteome analysis of the PNA^+^ and PNA^-^ subpopulations in stationary phase has also been performed. The PNA^-^ subpopulation is more infective in *L. major* [@pone.0113837-daSilva1] and *L. infantum* [@pone.0113837-Alcolea1] but the implications of the existence of this subpopulation in *Crithidia* spp. revealed herein is more likely related to development only. The new proteomic data, including the PNA^+^ and PNA^-^ subpopulations, have been compared with the outcome of published stage-specific transcriptome and proteome analyses in the genus *Leishmania*, what has revealed differences in abundance of proteins involved in gene expression regulation, carbohydrate metabolism, redox homeostasis and other processes.

Materials and Methods {#s2}
=====================

Parasite cultures {#s2a}
-----------------

Choanomastigotes of the *C. fasciculata* strain LLM494 [@pone.0113837-PerezCastineira1] were cultured at 27°C in complete medium containing RPMI 1640 medium supplemented with L-glutamine (Life Technologies, Carlsbad, CA), 10% heat inactivated foetal bovine serum (Lonza, Basel, Switzerland) and 100 µg/ml streptomycin -- 100 IU/ml penicillin (Life Technologies) pH 7.2. Cell density of three replicate cultures started at 2×10^6^ cells/ml was monitored and choanomastigotes were harvested daily at 2,000 g for 10 min and washed once with PBS at 4°C.

Purification of PNA {#s2b}
-------------------

100 g of non-roasted peanuts were submerged in 300 ml PBS at 4°C overnight, mashed and filtered through a gauze squeezing the homogenate to collect as much liquid as possible. Then, the homogenate was centrifuged at 8000 rpm for 10 min in a Sorvall RC5C centrifuge using a GSA rotor (Dupont, Stevenage, Herts, UK). The supernatant was recovered and clarified through filter paper. Then, 40% (w/v) (NH~4~)SO~4~ was progressively dissolved in the extract, which was then incubated at room temperature for 30 min. After 20 min of centrifugation at 6000 rpm, the supernatant was recovered and (NH~4~)SO~4~ progressively dissolved up to 75% (w/v). The extract was centrifuged again and the pellet recovered, resuspended in 50 ml PBS and dialyzed three times with 40 volumes of PBS at 4°C overnight. To clarify the extract, an additional centrifugation step at 6000 rpm for 10 min using an SS34 rotor and three filtration steps were carried out, the first one through filter paper, the second one through a 47 mm diameter, 2 µm pore size borosilicate fiber pre-filter (Millipore, Billerica, MA) and the third one through BioGel A2 (BioRad, Hercules, CA). Finally, the PNA was purified by affinity chromatography using melibiose immobilized in agarose beads (Sigma Aldrich, Buchs, Switzerland). Two washes with PBS were performed and the lectin eluted with 50 mM D-galactose (Sigma). The 1 ml fractions collected were quantified by the Warburg and Christian method [@pone.0113837-Warburg1].

Separation of PNA^+^ and PNA^-^ stationary phase choanomastigote subpopulations {#s2c}
-------------------------------------------------------------------------------

Stationary phase choanomastigotes were resuspended at 2 x 10^8^ cells/ml in complete medium containing 50 µg/ml PNA in a polypropylene tube. After 30 min incubation at room temperature allowing the sedimentation of agglutination complexes, the supernatant was recovered and the sediment was resuspended again in complete medium containing PNA at the same concentration. Sedimentation of both fractions was performed again but this time at 200 g for 10 min. The resulting supernatants were mixed and centrifuged at 2,000 g for 10 min to harvest PNA^-^ promastigotes, whereas only the pellet obtained from the original sediment was processed as the PNA^+^ fraction. All the steps of this procedure were checked at the light microscope (63X).

Preparation and quantification of protein extracts {#s2d}
--------------------------------------------------

We described a similar proteome analysis procedure [@pone.0113837-Alcolea2] and modifications are detailed herein. Each sample of parasites was resuspended in 300 µl lysis buffer (8.4 M urea, 2.4 M thiourea, 5% CHAPS, 50 mM DTT, 1% Triton X-100, 50 µg/ml DNase and Mini EDTA-free Protease Inhibitor Cocktail according to the manufacturer\'s instructions --Roche, Mannheim, Germany). The total protein extracts obtained were agitated by mild rotation at 4°C for 30 min, centrifuged at 8,000 g for 10 min and precipitated with methanol/chloroform [@pone.0113837-Wessel1]. All samples were dried at room temperature for 5 min and resuspended in 2X rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS, 0.003% bromophenol blue). Protein quantification was performed by the *RC DC protein assay* kit (BioRad). 50 µg aliquots of each sample were diluted to a final volume of 140 µl in 2X buffer containing 18.2 M DTT and 0.5% IPG buffer solution pH 3--10 (BioRad). Further confirmation was carried out by densitometric analysis of 10% PAGE-SDS gels [@pone.0113837-Laemmli1] as described [@pone.0113837-Alcolea2].

2DE separation and analysis of protein abundance {#s2e}
------------------------------------------------

Isoelectrofocusing of 50 µg total protein per sample was performed on IPG strips (non-linear pH 3--10 gradient, 7 cm, BioRad) in a *Protean IEF Cell* system (BioRad) following the manufacturer\'s instructions. A seven step program was used (50 V for 12 h, 250 V for 1 h, 500 V for 1 h, 1000 V for 1 h, 2000 V for 1 h, linear ramp to 8000 V for 1 h and 8000 V up to 3500 V·h). More than a total of 12,000 V·h were reached in all runs. The second dimension was run by 12% SDS-PAGE in a pre-cooled *MiniProtean 3 Dodeca Cell* system (BioRad) at 0.5 W/gel for 30 min and then at 1.5 W up to 5 min after the die-front reached the bottom edge of the gels (approximately 2 h). Then, the gels were stained with SYPRO Ruby protein gel stain (BioRad) following the manufacturer\'s instructions. Imaging was performed with *EXQuest Spot Cutter* system and the analysis of differential abundance with *PDQuest 2D Advanced 8.0.1* software (BioRad) following the manufacturer\'s instructions. First, all spots were automatically detected and thereafter manually checked by observation of single spot quantitation histograms and 2DE gel images. Normalized intensities were calculated by the *Total Quantity in Valid Spots* algorithm to ensure that relative quantification between gels is not biased by staining and background. The statistical analysis was performed by the Student\'s t-test at 0.05 significance level. Three replicates of each experiment were performed.

Protein identification by MALDI-TOF/TOF mass spectrometry {#s2f}
---------------------------------------------------------

The spots selected in the previous analysis were excised with *EXQuest Spot Cutter* (BioRad), digested with trypsin and prepared for MALDI-TOF/TOF mass-spectrometry as we described [@pone.0113837-Alcolea2]. A 0.8 µl drop of resuspended peptides from each spot was deposited in an *OptiTOF Plate* (Life Technologies) together with a 0.8 µl drop of a 3 g/l α-cyano-4-hydroxycinnamic solution (Sigma). The mixture was allowed to dry at room temperature. Samples were run in an *ABI 4800 MALDI-TOF/TOF* (Life Technologies) mass spectrometer in positive reflector mode at 25 kV for MS and 1 kV for MS/MS. The spectra were prepared with *ABI 4000 Series Explorer Software 3.6* (Life Technologies). Fingerprint and fragmentation spectra were run in *MASCOT 2.1* with *Global Protein Server Explorer 4.9* (Life Technologies) for protein identification with both the *NCBInr* database and annotations on the genome sequence of *C. fasciculata*. The genome sequence was completed at Washington University School of Medicine in St. Louis (Stephen Beverley, Richard Wilson) and assembly and annotations at Seattle Biomedical Research Institute (Peter Myler). These data can be retrieved from <http://tritrypdb.org/common/downloads/release-8.0/CfasciculataCfCl/fasta/data/>. A MIAPE-compliant report and the MS data have been deposited to the ProteomeXchange Consortium [@pone.0113837-Vizcaino1] via the PRIDE partner repository with the dataset identifier PXD001331 and DOI 10.6019/PXD001331.

Western blot {#s2g}
------------

Protein extracts were separated by SDS-PAGE in 8% slab gels (12 mA, 30 min; 30 mA, 90 min) in a *MiniProtean II Cell* system (BioRad). 20 µg protein extract was loaded per well including 1 µl Benzonase Nuclease HC (Novagen, Madison, WI). Blotting onto 0.45 µm nitrocellulose membranes (BioRad) was performed at 100 V for 1 h in a Mini Trans-Blot Cell wet transfer system (BioRad). Membrane blocking was carried out with 5% skimmed milk in PBS-0.1% Tween 20 (Sigma) for 1 h and washed three times with PBS-1% Tween 20 for 15, 5 and 5 min respectively. Next, membranes were incubated with 1∶500 of rabbit anti-LACK polyclonal serum for 2 h [@pone.0113837-GonzalezAseguinolaza1] or 1∶10,000 of monoclonal mouse anti-*L. mexicana* glycosomal GAPDH antibody kindly provided by Paul Michels (University of Edinburg) [@pone.0113837-GualdronLopez1], washed again and incubated with 1∶2,000 HRP-conjugated goat anti-rabbit IgG (DAKO, Ely, UK) for 90 min. Once the wash steps were repeated, the immunoblots were developed using the ECL detection system (GE Healthcare, Pittsburg, PA) according to the manufacturer\'s instructions.

Results and Discussion {#s3}
======================

Growth kinetics of *C. fasciculata* choanomastigotes and 2DE-MS/MS analysis {#s3a}
---------------------------------------------------------------------------

Choanomastigote cultures reached the stationary phase within 3 days ([Fig. 1B](#pone-0113837-g001){ref-type="fig"}), twice as fast as *Leishmania* spp. promastigotes. Similar growth kinetics of *C. fasciculata* choanomastigote clones has been reported [@pone.0113837-CaldernArguedasO1]. Total protein of 5×10^8^ choanomastigotes was extracted at early logarithmic (day 1), mid-logarithmic (day 2), late logarithmic/early stationary (day 3) and stationary phase (day 4). In addition, protein extracts were successfully obtained from the PNA^+^ and PNA^-^ subpopulations within the cultures in stationary phase. Protein concentrations were comprised between 4 and 9 µg/µl and this was confirmed by PAGE-SDS as described [@pone.0113837-Alcolea2]. After 2DE separations, normalization with the *Total Quantity in Valid Spots* algorithm and manual check of all the spots, 136 changes in abundance of proteins were detected throughout the four time points of the growth curve. Some proteins showed significant differences in abundance in more than one time point of the choanomastigote growth curve. The cut-off values were: ratio to day 1, R≥1.7 or≤0.6 within the significance level inferred with Student\'s t test (p\<0.05). Of these, 63 spots that correspond to 83 differences in abundance ([Fig. 2A--D](#pone-0113837-g002){ref-type="fig"}, [Table 1](#pone-0113837-t001){ref-type="table"}) were excised from the 2DE gels as they were suitable to be identified by MALDI-TOF/TOF. Therefore, 10 proteins are differentially expressed at two of the time points compared. We also analyzed 43 spots containing constantly expressed proteins ([Table 2](#pone-0113837-t002){ref-type="table"}), as well as 67 spots differentially expressed between the PNA^-^ and PNA^+^ subpopulations within the stationary phase culture ([Fig. 2E and F](#pone-0113837-g002){ref-type="fig"}, [Table 3](#pone-0113837-t003){ref-type="table"}). All proteins could be identified when MASCOT searches were performed against the reference genome sequence of *C. fasciculata* ([Tables 1](#pone-0113837-t001){ref-type="table"}--[3](#pone-0113837-t003){ref-type="table"}) when there was sufficient amount for identification, whereas a total of 20 constantly expressed proteins (Table S2 in [S1 File](#pone.0113837.s001){ref-type="supplementary-material"}), 41 differentially expressed proteins in the growth curve (Table S1 in [S1 File](#pone.0113837.s001){ref-type="supplementary-material"}) and 30 proteins with different abundance between PNA^+^ and PNA^-^ choanomastigotes (Table S3 in [S1 File](#pone.0113837.s001){ref-type="supplementary-material"}) could be identified against the *NCBInr* database, which is 53.4% of the proteins analyzed by MALDI-TOF/TOF mass spectometry. Most of the identifications (73.9%) were consistent between the two databases and most of those successfully performed with the *NCBInr* database (63.9%) had the highest MASCOT scores for orthologue proteins of the genus *Leishmania*, whereas only 9.3% of them matched with a *Trypanosoma* spp. orthologue (Tables S1--S3 in [S1 File](#pone.0113837.s001){ref-type="supplementary-material"}). This is additional evidence for the hypothesis supporting very close evolutionary relationship between *Leishmania* spp. and *Crithidia* spp [@pone.0113837-Stevens1], [@pone.0113837-Vickerman1], [@pone.0113837-Maslov1], [@pone.0113837-Hughes1]. Also, only 9.3% matched with *Crithidia* spp., as very few genes had been identified in this organism prior to the release of the reference genome sequence (Tables S1--S3 in [S1 File](#pone.0113837.s001){ref-type="supplementary-material"}). Sometimes, different spots represent the same type of protein. This may be due to the presence of different isoforms, post-translational modifications or protein aggregation at the conditions assayed. In the next sections, we refer to these possibilities using the term variant of a given protein.

![2DE of total protein extracts throughout the growth curve and of the PNA^+^ and PNA^-^ subpopulations of *C. fasciculata* choanomastigotes.\
2DE of 50 µg of total protein extracts of *C. fasciculata* choanomastigotes at (A) early logarithmic, (B) mid logarithmic, (C) late logarithmic and (D) stationary phase. (E) PNA^-^ and (F) PNA^+^ subpopulations. One out of three replicates is shown for each phase/subpopulation. IEF was performed in a non-linear 3--10 pH interval. Complete spot names include Cf (A--D) or Cf~p~ (E and F) preceding the spot numbers (see [Tables 1](#pone-0113837-t001){ref-type="table"}--[3](#pone-0113837-t003){ref-type="table"}).](pone.0113837.g002){#pone-0113837-g002}
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###### Differentially regulated proteins throughout the growth curve of *C. fasciculata* choanomastigotes.

![](pone.0113837.t001){#pone-0113837-t001-1}

  Spot                                                                 Protein                                                                            TriTryp Id.                MW (KDa)   *MASCOT* score (p\<0.05)   Ratio (p\<0.05)          
  -------- -------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ---------- -------------------------- ----------------- ------- -------
  Cf0202                                                Thiol-dependent reductase 1, putative                                                            CfaC1_35_0470                 26.5               187                    \_          0.01     \_
  Cf0601                                             Mitotubule-associated protein Gb4, putative                                                         CfaC1_33_0870                 45.0               48\*                  0.58          \_      \_
  Cf0908                                             Mitotubule-associated protein, Gb4, putative                                                        CfaC1_33_0870                170.0               455                   0.50          \_      \_
  Cf1101                                                 60S ribosomal protein L21, putative                                                             CfaC1_17_0510                 17.9               30\*                  0.01          \_      \_
  Cf1102                                               Eukaryotic initiaton factor 5a, putative                                                          CfaC1_28_1000                 22.2               44\*                  0.58          \_      \_
  Cf1103                                              Eukaryotic initiation factor 5a, putative                                                          CfaC1_28_1000                 23.6               271                   0.48          \_      \_
  Cf1202                                                   Hypothetical protein, conserved                                                               CfaC1_11_0220                 26.8               116                   0.44          \_      \_
  Cf1301                                              Translation elongation factor 1β, putative                                                         CfaC1_30_1700                 32.8               126                   0.58          \_      \_
  Cf1801                                               Peroxisomal targeting signal-1 receptor                                                           CfaC1_31_1260                 92.6                75                    \_          0.32     \_
  Cf1802                                                       Unnamed protein product                                                                    Cfa_19_1120                  70.4               144                    \_           \_     1.72
  Cf2303                                                         Hypothetical protein                                                                    CfaC1_16_2100                 33.6                90                   0.24          \_      \_
  Cf2401                                                         Unspecified product                                                                CfaC1_AODS01004023_0010            35.0                89                   0.21          \_      \_
  Cf2603                                                Thiol-dependent reductase 1, putative                                                            CfaC1_35_0470                 53.9               187                   3.18          \_      \_
  Cf2903                                                   Hypothetical protein, conserved                                                               CfaC1_22_0410                227.4               33\*                  89.60        0.18     \_
  Cf3202                                                     Phosphomannomutase, putative                                                                CfaC1_30_2340                 27.2               380                   1.78          \_      \_
  Cf3203                                              Tryparedoxin peroxidase (*C. fasciculata*)                                                   CfaC1_10_1430 (gi3851500)           24.1               138                    \_          3.28     \_
  Cf3401                                                      Transaldolase B, putative                                                                  CfaC1_17_0910                 36.1               299                   0.46          \_      \_
  Cf3403    CACK protein (*C. fasciculata*), activated protein kinase C receptor (LACK), guanine nucleotide-binding protein β subunit-like         CfaC1_26_3810 (gi3132790)           36.5               210                   0.58          \_      \_
  Cf3605                                                         Hypothetical protein                                                                    CfaC1_07_1350                 46.9               137                   2.34          \_      \_
  Cf3608                             Unspecified protein product (enolase orthologue)/Oxidoreductase-like protein                            CfaC1_AODS01003826_0010/CfaC1_22_0890     51.1               173                   1.73          \_      \_
  Cf3701                                              Chaperonin hsp60, mitochondrial precursor                                                          CfaC1_30_2420                 67.5               377                    \_          0.01     \_
  Cf3703                                                   Vacuolar ATP synthase subunit B                                                               CfaC1_26_3200                 55.8               426                   8.41          \_      \_
  Cf4001                                                         Unspecified protein                                                                CfaC1_AODS01003826_0010            15.9               173                   0.58          \_      \_
  Cf4204                                                       SNARE protein, putative                                                                   CfaC1_19_0830                 26.0               34\*                  0.03          \_      \_
  Cf4303                                                     Putative GTP-binding protein                                                                CfaC1_28_1830                 29.1               164                    \_           \_     1.76
  Cf4304                                              Aldose 1-epimerase-like protein, putative                                                          CfaC1_33_4840                 34.5               330                   1.84          \_     1.93
  Cf4501                                               Unspecified product (enolase orthologue)                                                     CfaC1_AODS01003826_0010            41.0               194                   0.50          \_      \_
  Cf4503                                               Unspecified product (Enolase ortologue)                                                      CfaC1_AODS01003826_0010            41.0               357                   0.56          \_      \_
  Cf4602                                                  Glutamate dehydrogenase, putative                                                              CfaC1_26_3700                 50.2               319                   2.12          \_      \_
  Cf4703                                            Pyruvate/indol pyruvate carboxylase, putative                                                        CfaC1_33_5440                 59.6               333                  458.61         \_      \_
  Cf5101                                                       Tryparedoxin peroxidase                                                             CfaC1_10_1430 (gi3851500)           12.9               186                   0.02          \_      \_
  Cf5203                                                         Hypothetical protein                                                                    CfaC1_19_1320                 26.5               154                   0.58          \_      \_
  Cf5301                                   Unspecified product (Glycosomal malate dehydrogenase orthologue)                                         CfaC1_AODS01001854_0010            34.2               106                   2.15          \_     2.85
  Cf5502                                                        Alcohol dehydrogenase                                                                    CfaC1_06_0480                40.87               642                    \_          0.58     \_
  Cf5601                                               Unspecified product (enolase orthologue)                                                     CfaC1_AODS01003826_0010            51.2               728                   1.84          \_      \_
  Cf5701                                                   Hypothetical protein, conserved                                                               CfaC1_30_4240                 55.9               279                   0.58          \_      \_
  Cf5703                                                           Pyruvate kinase                                                                       CfaC1_24_1930                 59.3                77                   3.94          \_      \_
  Cf5803                                                            Transketolase                                                                        CfaC1_30_4190                 75.7               193                   28.65        35.21   39.96
  Cf6001                                                        ADF/Cofilin, putative                                                                    CfaC1_14_1580                 15.0               235                   0.57          \_      \_
  Cf6002                                               Small myristoylated protein-1, putative                                                           CfaC1_19_1600                 15.4               233                   0.50         1.70     \_
  Cf6003                                                    Elongation factor 2, putative                                                                CfaC1_30_0260                 12.9               234                   0.01          \_      \_
  Cf6101                                                       Fe-superoxide dismutase                                                                   CfaC1_32_2350                 21.8               321                   0.58         1.72     \_
  Cf6102                                            NADP-dependent alcohol dehydrogenase, putative                                                       CfaC1_22_0610                 23.4                95                   0.37          \_      \_
  Cf6503                                                 NADP-dependent alcohol dehydrogenase                                                            CfaC1_22_0610                 40.4               267                   1.93          \_      \_
  Cf6602                                             Mitotubule-associated protein Gb4, putative                                                         CfaC1_33_0870                 45.6               134                    \_          11.1     \_
  Cf6603                                               Unspecified product (enolase orthologue)                                                     CfaC1_AODS01003826_0010            51.2               230                   80.53         \_      \_
  Cf6703                                                               Catalase                                                                          CfaC1_30_0050                 64.6               125                   3.44          \_      \_
  Cf6704                                                               Catalase                                                                          CfaC1_30_0050                 63.3               189                   3.26          \_      \_
  Cf6804                                                            Transketolase                                                                        CfaC1_30_4190                 75.6               125                   57.40         \_     72.40
  Cf7202                                            NADP-dependent alcohol dehydrogenase, putative                                                       CfaC1_22_0610                 24.2               125                   0.51          \_      \_
  Cf7302                                             Fructose-1,6-bisphosphate aldolase, putative                                                        CfaC1_30_1480                 32.9               418                   0.23          \_      \_
  Cf7402                                             Fructose-1,6-bisphosphate aldolase, putative                                                        CfaC1_30_1480                 36.8               407                   0.35         3.02     \_
  Cf7405                                             Fructose-1,6-bisphosphate aldolase, putative                                                        CfaC1_30_1480                 37.6               278                   0.29          \_      \_
  Cf7501                        Phosphoribosylpyrophosphate synthetase, putative, phosphoribosyl transferase, putative                                   CfaC1_04_0370                 42.7                60                    2.6          \_      \_
  Cf7603                                                  3-ketoacyl-CoA thiolase, putative                                                              CfaC1_22_1180                 47.4               607                   1.74          \_      \_
  Cf7604                                       Pyruvate dehydrogenase component E1 a-subunit, putative                                                   CfaC1_21_1950                 44.4               143                   57.93         \_      \_
  Cf7703                          Succinyl-CoA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative                                      CfaC1_04_0870                 56.7               189                   2.22          \_     2.14
  Cf7704                                               Dihydrolipoamide dehydrogenase, putative                                                          CfaC1_32_4840                 54.8               507                   2.72          \_      \_
  Cf8402                                                         Malate dehydrogenase                                                                    CfaC1_33_1570                 34.9               663                   2.38          \_      \_
  Cf8504                                             Fructose-1,6-bisphosphate aldolase, putative                                                        CfaC1_30_1480                 42.8               594                   2.93          \_      \_
  Cf8601                                                              Hexokinase                                                                         CfaC1_31_0400                 49.3               683                   4.62          \_     4.83
  Cf8701                                                         Hypothetical protein                                                                    CfaC1_32_1140                 62.5               349                   0.50          \_      \_
  Cf9302                                   Unspecified product (glycosomal malate dehydrogenase orthologue)                                         CfaC1_AODS01001854_0010            33.7               379                   1.99          \_      \_

Estimated MW, pI, MASCOT scores (\*non-significant) and ratios to day 1 are provided. Only spots with statistically significant ratios (p\<0.05) over 1.7 or under 0.6 were picked and analyzed and are shown in this table. As a consequence, hyphens in the columns containing ratios do not necessarily indicate lack of differential abundance, because there are also cases of lack of statistical significance of ratios indicating over- or under-expression. Identifications were performed against the *C. fasciculata* genome sequence released in the TriTryp database.

10.1371/journal.pone.0113837.t002

###### Constantly expressed proteins throughout the growth curve of *C. fasciculata* choanomastigotes.

![](pone.0113837.t002){#pone-0113837-t002-2}

  Spot                                  Protein                                           TriTrypDB Id.               MW (KDa)   pI    MASCOT score (p\<0.05)
  -------- ----------------------------------------------------------------- --------------------------------------- ---------- ----- ------------------------
  Cf1001                      ATP-dependent RNA-helicase                                  CfaC1_32_0820                17.91     4.5            28\*
  Cf1602                    META domain-containing protein                                CfaC1_15_1260                52.82     4.6            613
  Cf1904                         Hypothetical protein                                     CfaC1_24_0880                105.02    4.4            569
  Cf2201                    Hypothetical protein, conserved                               CfaC1_33_5560                27.96     5.2            38\*
  Cf2702                         Hypothetical protein                                     CfaC1_16_2100                60.31     4.7            50\*
  Cf2703                          ATG8/AUT7/APG8/PAZ2                                     CfaC1_19_0910                57.83     5.0            28\*
  Cf2804                        Unnamed protein product                                   CfaC1_24_2570                91.86     5.0            122
  Cf2805                         Hypothetical protein                                     CfaC1_26_3570                76.77     5.3           150\*
  Cf2901                          Unspecified protein                                  CfaC1_KB217687_0080             171.73    4.7            32\*
  Cf4201              Proteasome activator protein pa26, putative                         CfaC1_24_2680                25.11     5.7            337
  Cf4202                  Short chain dehydrogenase, putative                             CfaC1_31_1020                27.95     5.7            132
  Cf4301              Biotin/lipoate protein ligase-like protein                          CfaC1_34_1660                28.88     5.7            109
  Cf4302    Prostaglandin f2α synthase/D-arabinose dehydrogenase, putative                CfaC1_34_3900                33.04     5.7            114
  Cf4401                    Thymine 7-hydroxylase, putative                             CfaC1_14_1860/70               36.76     5.8             60
  Cf6202                  Iron superoxide dismutase, putative                             CfaC1_25_0490                25.01     6.1             55
  Cf6401                    Coproporphyrinogen III oxidase                                CfaC1_24_0220                35.33     6.1            687
  Cf6402              Methylthioadenosine phosphorylase, putative                         CfaC1_05_0930                37.29     6.1            101
  Cf6501                 NADP-dependent alcohol dehydrogenase                             CfaC1_22_0610                40.91     6.0            181
  Cf6502         Branched-chain amino acid aminotransferase, putative                     CfaC1_27_2440                42.86     6.1            184
  Cf6506                          Arginase, putative                                      CfaC1_31_1380                39.73     6.3            123
  Cf6507         Chaperone protein DNAJ, putati ve/Unspecified product        CfaC1_32_4400/CfaC1_AODS01001585_0010    42.47     6.3          40/40\*
  Cf6708       Aldehyde dehydrogenase, mitocondrial precursor, putative                   CfaC1_28_1490                55.55     6.1            256
  Cf6901                               Aconitase                                          CfaC1_21_0760                104.44    6.4            454
  Cf7002                     Nucleoside diphosphate kinase                                CfaC1_32_3660                16.09     6.7            295
  Cf7201               Ribulose phosphate 3-epimerase, putative                           CfaC1_31_3770                27.35     6.4             85
  Cf7204                        ATP synthase, putative                                    CfaC1_35_2640                27.71     7.5            176
  Cf7301                          RNA-binding protein                                     CfaC1_31_2330                37.67     6.5            433
  Cf7601               Aldose 1-epimerase-like protein, putative                          CfaC1_24_2950                46.66     6.4            148
  Cf7602                 Phosphoglycerate kinase B, cytosolic                             CfaC1_23_0180                46.54     6.5            621
  Cf7705        Glycosomal phosphoenolpyruvate carboxykinase, putative                    CfaC1_27_2690                62.20     6.7            191
  Cf8102                        Cyclophilin A, putative                                   CfaC1_28_1250                19.39     8.6            356
  Cf8104                        Cyclophilin 4, putative                                   CfaC1_04_0140                22.57     9.1            252
  Cf8202                      Triose phosphate isomerase                                  CfaC1_27_0920                24.89     7.5            295
  Cf8203            Triose phosphate isomerase (*L. braziliensis*)                        CfaC1_27_0920                25.02     8.3            126
  Cf8204                  RNA-binding protein, putative, UPB2                             CfaC1_28_0710                24.03     9.1            103
  Cf8301                         Hypothetical protein                                     CfaC1_18_0790                31.53     8.7            125
  Cf8302              Succinyl-CoA synthetase α-subunit, putative                         CfaC1_02_0750                33.63     8.7            124
  Cf8501               Aldose 1-epimerase-like protein, putative                          CfaC1_24_2950                41.01     8.0            509
  Cf8502    Hypothetical protein, conserved/Hypothetical protein, conserved        CfaC1_35_4400/CfaC1_33_5170         39.25     8.3          36/36\*
  Cf8702                       Poly(A)-binding protein 2                                  CfaC1_31_0480                68.60     9.0            352
  Cf9301                Hypothetical protein, conserved (gMDH)                            CfaC1_13_1170                31.77     9.2            272
  Cf9401                    Elongation factor 1α, putative                                CfaC1_15_0180                36.35     9.3            149
  Cf9601                     Elongation factor 1α, partial                                CfaC1_15_0180                53.84     9.2            165

Estimated MW, pI and MASCOT scores (\*non-significant) are provided. Identifications were performed against the *C. fasciculata* genome sequence released in the TriTryp database.

10.1371/journal.pone.0113837.t003

###### Differential abundance of proteins between the PNA^+^ and PNA^-^ subpopulations of *C. fasciculata* choanomastigotes in stationary phase of axenic culture.

![](pone.0113837.t003){#pone-0113837-t003-3}

  Spot                                           Protein                                                     TriTryp DB Id.                    MW (KDa)   pI    *MASCOT* score (p \<0.05)   Ratio (PNA^+^):(PNA^-^) (p \<0.05)
  ----------- ----------------------------------------------------------------------------- ------------------------------------------------- ---------- ----- --------------------------- ------------------------------------
  Cf~p~0104                          Eukaryotic initiation factor 5a                                          CfaC1_28_1000                     20.52     3.5              70                              0.44
  Cf~p~0803                    Mitotubule-associated protein Gb4, putative                                    CfaC1_33_0870                     73.19     3.4              388                             0.02
  Cf~p~0903                    Mitotubule-associated protein Gb4, putative                                    CfaC1_33_0870                     130.8     3.3              161                             0.29
  Cf~p~1203                               Hypothetical protein                                                CfaC1_16_2100                     35.48     3.8              102                             0.17
  Cf~p~1803                               Hypothetical protein                                                CfaC1_26_3570                     86.91     4.7              125                             0.41
  Cf~p~1901                          Hypothetical protein, conserved                                          CfaC1_24_0880                     142.13    4.3              354                             0.14
  Cf~p~2402                     Hypothetical protein/Unspecified product                          CfaC1_27_1220/CfaC1_AODS01003272_0020         34.22     5.2             24/23                            0.57
  Cf~p~2801       2,3-bisphosphoglycerate-independent phosphoglycerate mutase, putative                       CfaC1_35_3710                     76.42     5.0              483                             0.40
  Cf~p~2802                               Carboxylase, putative                                               CfaC1_12_0120                     88.35     5.1              175                             0.15
  Cf~p~2901                            Oligopeptidase B, putative                                             CfaC1_12_1200                     92.75     5.4              59                              0.03
  Cf~p~3001                  NADP-dependent alcohol dehydrogenase, putative                                   CfaC1_22_0610                     18.46     5.5             40\*                             0.01
  Cf~p~3002                                Unspecified product                                                CfaC1_19_1390                     19.12     5.4             22\*                             0.07
  Cf~p~3101                    Tryparedoxin peroxidase (*C. fasciculata*)                               CfaC1_10_1430 (gi385150)                22.36     5.4              169                             0.01
  Cf~p~4002                          Nucleoside diphosphate kinase b                                          CfaC1_32_3660                     10.52     5.5             38\*                             0.03
  Cf~p~4202                                GTP-binding protein                                                CfaC1_28_2830                     23.10     5.6              133                             0.03
  Cf~p~4302                     Aldose 1-epimerase-like protein, putative                                     CfaC1_33_4840                     28.68     5.6              82                              0.52
  Cf~p~4501                      Unspecified product/Unspecified product                     CfaC1_AODS01001347_0030/CfaC1_AODS01003093_0020    42.76     5.6             60/60                            0.48
  Cf~p~5001                           Endoribonuclease L-PSP (pb5)                                            CfaC1_22_0370                     14.23     5.9              82                              0.56
  Cf~p~5002                       60S ribosomal protein L37a, putative                                 CfaC1_16_2060/CfaC1_30_2280              18.15     5.7            25/25\*                           0.02
  Cf~p~5101                    Tryparedoxin peroxidase (*C. fasciculata*)                               CfaC1_10_1430 (gi385150)                20.46     5.7              174                             0.46
  Cf~p~5201                      Insufficient amount for identification                                            \-                           27.17     5.8              \-                              0.09
  Cf~p~5301                   Unnamed protein product (enolase orthologue)                               CfaC1_AODS01003826_0010                41.26     5.7              442                             0.33
  Cf~p~5401                  Nucleoside phosphorylase-like protein, putative                                  CfaC1_18_1820                     36.22     5.6              57                              0.03
  Cf~p~5504                       Methionine aminopeptidase 2, putative                                       CfaC1_16_0810                     43.54     5.8             29\*                             0.04
  Cf~p~5701                               Hypothetical protein                                                CfaC1_05_0410                     60.28     5.7             36\*                             0.31
  Cf~p~5702                          Hypothetical protein, conserved                                          CfaC1_30_4240                     47.91     5.9              170                             0.57
  Cf~p~5901                           Elongation factor 2, putative                                           CfaC1_30_0260                     171.5     5.8              59                              0.54
  Cf~p~6001                              Fe-superoxide dismutase                                              CfaC1_32_2350                     19.25     6.0              356                             0.59
  Cf~p~6101                             Iron superoxide dismutase                                             CfaC1_25_0490                     23.09     6.0              96                              0.56
  Cf~p~6102                      Insufficient amount for identification                                            \-                           25.23     6.0              \-                              0.06
  Cf~p~6401                          Coproporphyrinogen III oxidase                                           CfaC1_24_0220                     38.52     6.1              533                             0.28
  Cf~p~6504                               Hypothetical protein                                                CfaC1_19_0530                     44.34     5.9             25\*                             0.05
  Cf~p~6602                      Insufficient amount for identification                                            \-                           46.81     6.0              \-                              0.07
  Cf~p~7001          Hypothetical protein, conserved/Hypothetical protein, conserved                        CfaC1_35_5730/40                    19.87     6.2             36/35                            0.03
  Cf~p~7101                  NADP-dependent alcohol dehydrogenase, putative                                   CfaC1_22_0610                     23.37     6.3             25\*                             0.01
  Cf~p~7701                                Catalase, putative                                                 CfaC1_30_0050                     59.30     6.1              83                              0.03
  Cf~p~7403                               Hypothetical protein                                                CfaC1_30_0060                     36.21     6.3              130                             0.03
  Cf~p~7502                          Aldose 1-epimerase-like protein                                          CfaC1_24_2950                     53.96     6.3              169                             0.64
  Cf~p~7702                                     Catalase                                                      CfaC1_30_0050                     87.42     6.2              159                             0.53
  Cf~p~7704                                     Catalase                                                      CfaC1_30_0050                     87.11     6.3              215                             0.36
  Cf~p~7804                           Fumarate hydratase, putative                                            CfaC1_25_2280                     98.56     6.1              95                              0.06
  Cf~p~8101                          Hypothetical protein, conserved                                          CfaC1_28_2780                     24.22     6.5             21\*                             0.08
  Cf~p~8401                               Hypothetical protein                                                CfaC1_26_0530                     39.90     6.5             24\*                             0.04
  Cf~p~8404                      Insufficient amount for identification                                            \-                           36.55     7.0              \-                              0.05
  Cf~p~8501                      Insufficient amount for identification                                            \-                           41.22     6.3              \-                              0.04
  Cf~p~8704                      Insufficient amount for identification                                            \-                           52.18     6.4              \-                              0.09
  Cf~p~9002                      Insufficient amount for identification                                            \-                           20.12     9.5              \-                              0.01
  Cf~p~9003                      Insufficient amount for identification                                            \-                           16.98     9.5              \-                              0.02
  Cf~p~9602                          Elongation factor 1α, putative                                           CfaC1_15_0180                     71.43     9.3              447                             0.01
  Cf~p~1301                         Sphingosine kinase A, B, putative                                         CfaC1_08_0670                     36.09     4.6             32\*                             3.31
  Cf~p~1801                       Dipeptidylcarboxypeptidase, putative                                        CfaC1_27_1750                     70.35     3.5             38\*                            12.43
  Cf~p~1804                               Hypothetical protein                                                CfaC1_13_1510                     71.01     4.9             38\*                            503.6
  Cf~p~3502                                TATE DNA transposon                                                CfaC1_19_2160                     49.69     5.5             22\*                             1.96
  Cf~p~4801                               Hypothetical protein                                                CfaC1_50_0070                     78.23     5.7             38\*                             3.31
  Cf~p~5602                      Insufficient amount for identification                                            \-                           56.13     6.9              \-                             40.85
  Cf~p~6402                  NADP-dependent alcohol dehydrogenase, putative                                   CfaC1_22_0610                     44.01     6.5              177                             1.77
  Cf~p~6403                  NADP-dependent alcohol dehydrogenase, putative                                   CfaC1_22_0610                     44.01     6.5             39\*                            98.62
  Cf~p~6802                              Transketolase, putative                                              CfaC1_30_4190                     81.44     6.4              109                             2.69
  Cf~p~7302                    Fructose-1,6-bishosphate aldolase, putative                                    CfaC1_30_1480                     39.05     6.2              270                             1.92
  Cf~p~7801                          Hypothetical protein, conserved                                          CfaC1_18_1860                     90.58     6.6             52\*                            59.04
  Cf~p~8701    Succinyl-CoA: 3-ketoacid-CoA transferase, mitochondrial precursor, putative                    CfaC1_04_0870                     75.28     6.5              129                             2.01
  Cf~p~9203         Unspecified product (glycosomal malate dehydrogenase orthologue)                     CfaC1_AODS01001854_0010                35.74     9.6              188                             3.16
  Cf~p~9501                   Fructose-1,6-bisphosphate aldolase, putative                                    CfaC1_30_1480                     48.93     9.2              526                             1.89
  Cf~p~9206                      Insufficient amount for identification                                            \-                           31.88     9.4              \-                             50.78
  Cf~p~9207                      Insufficient amount for identification                                            \-                           31.29     8.5              \-                             49.33
  Cf~p~9601                                    Hexokinase                                                     CfaC1_31_0400                     61.24     9.2              611                             7.26
  Cf~p~9703                      Insufficient amount for identification                                            \-                           64.73     8.3              \-                              0.68

Estimated molecular weights, pI, MASCOT scores (\*non-significant) and PNA^+^/PNA^-^ ratios. Only spots with statistically significant ratios (p\<0.05) over 1.7 or under 0.6 were picked and analyzed and are shown in this table. Identifications were performed against the *C. fasciculata* genome sequence released in the TriTryp database.

Peanut lectin agglutination capability of choanomastigotes {#s3b}
----------------------------------------------------------

It is known that certain species of *Leishmania* agglutinate with PNA and a non-agglutinating subpopulation can be isolated [@pone.0113837-daSilva1], [@pone.0113837-Alcolea1]. This is the first time that the agglutination properties of *Crithidia* spp. choanomastigotes with PNA have been assayed and the outcome has been a noticeable agglutination capability and the isolation of a non-agglutinating population in stationary phase. These findings support a modification of the *Crithidia* spp. lipoarabinogalactans (LAG) at the end of the growth curve analogous to that taking place in the lipophosphoglycan (LPG) of *Leishmania* spp., even when the structure of the LAG [@pone.0113837-Schneider1], the surface molecules that presumably agglutinate with the lectin in this genus, is quite different to the leishmanial LPG. The biological roles of the respective agglutinating surface molecules involved are probably different in these organisms given the differences in their life cycles. *L. major* and *L. infantum* promastigotes are able to agglutinate with PNA and the non-agglutinating subpopulations are more infective and lead to higher infection rates than the agglutinating ones, yielding more infected phagocytes and amastigotes per infected cell [@pone.0113837-daSilva1], [@pone.0113837-Alcolea1]. Promastigotes attach to the gut epithelium by the LPG to maintain infection during bloodmeal excretion and only with differentiation signals as starvation, a developmental process ultimately leading to metacyclic promastigotes is triggered (reviewed in [@pone.0113837-Sacks1]). The differentiation process is widely recognized to be mimicked in axenic culture, where starvation also takes place when promastigotes reach the stationary phase.

The change in LAG composition of *C. fasciculata* is likely due to developmental processes according to the findings described herein (see below) but does not provide evidence to be associated to any process related with infectivity. In fact, the next step in the life cycle of this parasite is differentiation to the extracellular amastigote stage that attaches to the gut epithelium of the insect host.

Changes in abundance of proteins involved in glucid catabolism and the pentose phosphate pathway {#s3c}
------------------------------------------------------------------------------------------------

According to proteome profiling, glycolysis is more active in early and mid logarithmic phase ([Fig. 3](#pone-0113837-g003){ref-type="fig"}, [Table 1](#pone-0113837-t001){ref-type="table"}), when several protein variants alternate. In fact, two aldolase (ALD) and two enolase variants are up-regulated at day 1 but at the second day, their expression levels decay and are replaced by distinct ones, respectively one ALD and two enolases. Additionally, an hexokinase (HK) variant, the pyruvate kinase (PyrK), a putative and a glycosomal malate dehydrogenase (MDH) and the components of the pyruvate dehydrogenase complex (PDH) dihydrolipoamide dehydrogenase (DLD) and E1α are more abundant at day 2 (mid logarithmic phase), which suggests higher activity of hexose catabolic processes and malate shuttles, provided that most of the glucolytic reactions take place in the glycosome of these organisms (reviewed in [@pone.0113837-Parsons1]). In fact, other monosaccharides may be increasingly utilized by choanomastigotes in mid logarithmic phase as additional carbon and energy sources and/or to provide precursors for the biosynthesis of glycans. This is suggested on the basis of the wide substrate specificity of the HK and the up-regulation of the phosphomannomutase (PMM) and the aldose 1-epimerase (AEP). The PMM is involved in the biosynthesis of N-glycans providing manose-1-phosphate, as the reaction is reversible. The AEP is also up-regulated at the stationary phase, especially in PNA^-^ choanomastigotes ([Tables 1](#pone-0113837-t001){ref-type="table"} and [3](#pone-0113837-t003){ref-type="table"}). As highlighted in [Fig. 3](#pone-0113837-g003){ref-type="fig"}, the up-regulation of these ALD variants may yield high levels of glyceraldehyde-3-phosphate not only for the subsequent glucolytic reactions but also for the pentose-phosphate shunt, provided the up-regulation of the transaldolase B (TALDO) at early logarithmic phase (day 1) and the transketolase (TKETO) at mid logarithmic and stationary phase. These proteins are related functionally with the phosphoribosyl pyrophosphate synthase (PRPPS), which is more abundant at day 2. These findings are indicative of maximum activity of the glucolytic pathway at mid logarithmic phase providing energy and essential precursors of certain amino acids, ribonucleotides and derived coenzymes. By contrast, the highest expression levels of genes involved in glucolysis are found in *L. infantum* promastigotes in stationary phase [@pone.0113837-Alcolea3] and differential regulation of genes involved in the pentose phosphate shunt has not been detected up to date in these pathogenic trypanosomatids.

![Differentially expressed proteins related with carbohydrate metabolic processes in *C. fasciculata* choanomastigotes.\
Functional connection of differentially expressed enzymes involved in glucid metabolic processes. Legend: proteins/protein variants in blue are constitutively expressed throughout the growth curve; proteins/protein variants in orange are up-regulated at day 1 or 2 (logarithmic phase); proteins/variants in green are up-regulated at day 3 or 4 (late logarithmic/stationary phase); proteins in red are up-regulated in PNA^+^ choanomastigotes; proteins in purple are up-regulated in PNA^-^ choanomastigotes.](pone.0113837.g003){#pone-0113837-g003}

The up-regulation of two alcohol dehydrogenases (ADH) at early logarithmic phase is also related with sugar catabolism, as a relative inefficiency of the respiratory process and the finding of subproducts as ethanol and lactate were described in trypanosomatids (reviewed in [@pone.0113837-Cazzulo1]). Alternation in up-regulation between ADH variants has been detected between PNA^+^ and PNA^-^ choanomastigotes ([Table 3](#pone-0113837-t003){ref-type="table"}), and there are also constitutive and differentially regulated variants of ADH and MDH.

In certain cases, only proteins that catalyze irreversible reactions and/or control the kinetics of the metabolic process are increasingly abundant, whereas those catalyzing reversible and non-limiting steps are constitutively expressed. This is the case of the expression profile of glycolytic enzymes in *C. fasciculata* choanomastigotes as the triose phosphate isomerase (TPI) and the phosphoglycerate kinase (PGK) ([Fig. 3](#pone-0113837-g003){ref-type="fig"}, [Table 2](#pone-0113837-t002){ref-type="table"}) are constitutively expressed unlike others mentioned above. Conversely, an *L. infantum* orthologue of the PGK reaches its highest abundance in stationary phase promastigotes at the transcript level [@pone.0113837-Alcolea3]. The aconitase is up-regulated in the promastigote stage with respect to amastigotes in *L. infantum* [@pone.0113837-Brotherton1] and the opposite profile was observed in *L. donovani* [@pone.0113837-Rosenzweig1], but the *C. fasciculata* orthologue is constitutively expressed in the choanomastigote stage.

Several enzymes related with sugar metabolism are also differentially regulated between PNA^+^ and PNA^-^ choanomastigotes within the stationary phase. The PGM^BPI^ and the enolase are over-expressed, suggesting that only the second part of glycolysis is more active in PNA^-^ choanomastigotes in a bisphosphoglycerate-independent manner. As a difference with mammalian organisms, the trypanosomatid genomes encode the PGM^BPI^, which suggests that this protein is a good drug target [@pone.0113837-Chevalier1]. Interestingly, this enzyme is differentially regulated between different life cycle stages in *L. infantum* [@pone.0113837-Alcolea3] and also in *C. fasciculata* according to the analysis described herein. The expression patterns of the HK, ALD and TKETO are the opposite to those of the PGM^BPI^ and the enolase. Consequently, the expression profile of the glycolytic and the pentose phosphate pathway are the same in the PNA^+^ subpopulation and the whole population in stationary phase ([Table 3](#pone-0113837-t003){ref-type="table"}). The finding is coherent as this is the major subpopulation at that growth phase.

The heme biosynthetic enzyme coproporphyrinogen (III) oxidase (C(III)O) is up-regulated in PNA^-^ *C. fasciculata* choanomastigotes ([Table 3](#pone-0113837-t003){ref-type="table"}) whereas it is constitutively expressed throughout the growth curve ([Table 2](#pone-0113837-t002){ref-type="table"}). Differential expression was not observed during axenic growth of *L. infantum* promastigotes either and it was revealed that C(III)O is up-regulated in intracellular amastigotes [@pone.0113837-Alcolea3] and axenic amastigotes obtained by temperature and pH shift [@pone.0113837-Alcolea4]. The heme group is necessary for a variety of cellular functions in *Leishmania* spp., including not only the electron transport chain, but also the catalase, which is also over-expressed in the PNA^-^ subpopulation (see below).

Changes in abundance of proteins involved in lipid metabolism {#s3d}
-------------------------------------------------------------

Fatty acid biosynthesis, ketone body degradation, β-oxidation of fatty acids and/or branched chain amino acid degradation is probably more activated at day 2 because a putative 3-ketoacid-CoA thiolase (KAT) is up-regulated. This may be linked with the up-regulation of the succinyl-CoA:3-ketoacid-CoA transferase (SCAT), which suggests the utilization of ketone bodies in *C. fasciculata* mid logarithmic phase choanomastigotes, which is of unknown meaning in trypanosomatids. The existence of ketone bodies in trypanosomatids was tested by ^1^H NMR in *L. donovani* axenic amastigotes [@pone.0113837-Gupta1]. These molecules are probably mere intermediate metabolites in these organisms. Given that the SCAT catalyzes the split of acetoacetate into two acetyl-CoA molecules, a probable explanation for its up-regulation may be that it is involved in the last step of Leu degradation, as well as KAT up-regulation suggests a role in Ile catabolism and the DHL in degradation of all branched chain amino acids. Conversely, thiolases reach their highest expression levels in stationary phase promastigotes in *L. infantum* [@pone.0113837-Alcolea3]. The SCAT is down-regulated in the PNA^-^ choanomastigote subpopulation, which indicates a decrease throughout choanomastigote development taken together with the results obtained for the growth curve.

Changes in abundance of proteins involved in gene expression regulation and signal transduction {#s3e}
-----------------------------------------------------------------------------------------------

A decreased translational elongation rate is expected throughout the growth curve of choanomastigotes, as the abundance of the eukaryotic translation initiation factor 5a (eIF5a), the translation elongation factor 1β (EF1β) and the elongation factor 2 (EF2) decreases. This is likely due to the higher metabolic activity and faster growth in logarithmic phase choanomastigotes. However, other proteins involved in gene expression regulation that are differentially abundant in *L. infantum* promastigotes [@pone.0113837-Alcolea3], [@pone.0113837-Alcolea5] are constitutively expressed conversely in *C. fasciculata* choanomastigotes: the EF1α, a poly(A) binding protein (PABP2), two RNA-binding proteins (RNA bp) and an ATP-dependent RNA helicase ([Table 2](#pone-0113837-t002){ref-type="table"}). These proteins may be involved in developmental processes rather than in growth in *Leishmania* spp. promastigotes. A similar hypothesis can be posed to explain the up-regulation of the eIF5a, the EF1α, the EF2 and the endoribonuclease L-PSP in the PNA^-^ choanomastigotes, as this minor subpopulation was isolated from culture in stationary phase, where growth conditions would not explain an increase on the translation rate. The transcript levels of PABP are also higher in *L. infantum* PNA^-^ promastigotes, but those of the EF1α were significantly lower, thus being the expression profile the opposite [@pone.0113837-Alcolea1]. In fact, three variants of the EF1α protein are more abundant in stationary phase promastigotes, where the PNA^+^ promastigote subpopulation is by far the more represented [@pone.0113837-Alcolea2]. Future in depth analysis of these differences between both parasites may aid to explain why their developmental processes are different.

As for protein folding, only a variant of the hsp60 chaperonin is more abundant in early logarithmic phase choanomastigotes, whereas other variant of this protein, a DnaJ domain-containing protein, two cyclophilins and the adenosine kinase domain-containing nucleoside diphosphate kinase b (Ndkb) are constitutively expressed throughout the growth curve of axenic choanomastigotes. These findings also contrast with results found in *L. infantum* promastigotes [@pone.0113837-Alcolea1], [@pone.0113837-Alcolea2], [@pone.0113837-Alcolea3], [@pone.0113837-Alcolea5]. To put an example, a cyclophilin is up-regulated in stationary phase promastigotes in *L. infantum*.

Regarding intracellular signalling, the *C. fasciculata* analogue (CACK) (gi3132790; CfaC1_26_3810) of the receptor of the activated protein kinase C (RACK) is up-regulated in early logarithmic phase choanomastigotes (day 1) ([Fig. 2](#pone-0113837-g002){ref-type="fig"}, [Table 1](#pone-0113837-t001){ref-type="table"}). This expression profile has been confirmed by Western blot ([Fig. 4](#pone-0113837-g004){ref-type="fig"}, Figures S1 and S2 in [S2 File](#pone.0113837.s002){ref-type="supplementary-material"}), which has revealed the progressive descent of CACK abundance throughout the choanomastigote growth curve. The leishmanial orthologue LACK, an antigenic protein that partially protects against canine leishmaniasis [@pone.0113837-Ramiro1], [@pone.0113837-Ramos1], [@pone.0113837-Ramos2], is located in the particulate fraction of the cytoplasm near the plasma membrane. LACK is up-regulated in *L. infantum* amastigotes but constantly expressed in promastigotes [@pone.0113837-GonzalezAseguinolaza1], [@pone.0113837-Alcolea3]. Consequently, the CACK/LACK expression patterns in the motile stages of *C. fasciculata* and *L. infantum* are different, what suggests different roles in proliferation and differentiation in their respective life cycles. PKCs are translocated by their receptor (RACK) to different intracellular sites [@pone.0113837-MochlyRosen1] and activated via phospholipase C or Ca^2+^. PKCs and RACKs are involved in a variety of characterized signal transduction cascades in mammals [@pone.0113837-Mellor1]. However, their role in specific pathways is unknown in these parasites. Although the kinomes of trypanosomatids are well characterized [@pone.0113837-Parsons2], the signaling pathways may not be necessarily the same as in other organisms like yeasts and mammals. Signaling proteins are expected to regulate gene expression but most of the specific mechanisms and pathways have not been unraveled yet and may be different given the unique features of gene expression in these parasites (reviewed in [@pone.0113837-Clayton1]). The unknown specific function of this protein in signaling may be especially important in *Leishmania* spp. for resistance of amastigotes inside the parasitophorous vacuole of the host phagocyte cell whereas the only colonization step of the *Crithidia* spp. life cycle is the infection of the gut of the insect host. CACK and LACK seem to be important for growth and/or development of the motile stages of the respective species they belong to, as up-regulation in *C. fasciculata* logarithmic phase choanomastigotes has been found herein and its leishmanial orthologue is one of the 50 most abundant transcripts of *L. major* promastigotes [@pone.0113837-Rastrojo1].

![CACK is up-regulated in logarithmic phase choanomastigotes.\
Detection and differential expression analysis of CACK in 20 µg total protein extracts by Western blot with 1∶500 polyclonal antibody against the LACK analogue throughout the choanomastigote growth curve. The ∼60 KDa band presumably contains dimeric CACK aggregates (González-Aseguinolaza et al., 1999). gGAPDH is the protein of reference (dilution 1∶10,000 of the monoclonal antibody).](pone.0113837.g004){#pone-0113837-g004}

Changes in abundance of proteins involved in thiol-based redox homeostasis {#s3f}
--------------------------------------------------------------------------

The TryP of *C. fasciculata* previously characterized [@pone.0113837-Tetaud1] (gi3851500; CfaCl_10_1430) is over-expressed in mid logarithmic phase choanomastigotes, as well as the thiol-dependent reductase 1 (TDR1) ([Table 1](#pone-0113837-t001){ref-type="table"}, [Fig. 5](#pone-0113837-g005){ref-type="fig"}). This is an important difference with promastigotes of *L. major*, an ethiological agent of cutaneous leishmaniasis in the Old World, as TryP is constitutively expressed in all the stages of its life cycle [@pone.0113837-Leifso1], [@pone.0113837-Levick1]. It is also known that *L. donovani* amastigotes up-regulate the TryP with respect to promastigotes [@pone.0113837-Rosenzweig1]. The catalase is absent in pathogenic trypanosomatids [@pone.0113837-Opperdoes1] but not in *C. fasciculata*. In fact, variants matching with the annotations CfaCl_30_0050 have been identified in several spots ([Tables 1](#pone-0113837-t001){ref-type="table"} and [3](#pone-0113837-t003){ref-type="table"}). For this reason, hydrogen peroxide removal in *C. fasciculata* is not necessarily dependent on trypanothione-linked peroxidases, as a difference with the pathogenic trypanosomatids. Like the TryP, this protein is more abundant at mid logarithmic phase. These data suggest higher levels of oxidative stress counteracted with TDR1, TryP and catalase up-regulation in *Crithidia* spp. choanomastigotes than in *Leishmania* spp. promastigotes at mid logarithmic phase, possibly due to the greater growth rate observed in the former ([Fig. 1](#pone-0113837-g001){ref-type="fig"}). In fact, the stationary phase is reached about 5--7 days in a typical growth curve of *Leishmania* spp. (e.g., [@pone.0113837-Alcolea3]). The up-regulation of TDR1 suggests that the glutathione-ascorbate cycle is also participating in counteracting oxidative stress.

![Differentially expressed proteins involved in redox homeostasis and translation in *C. fasciculata* choanomastigotes.\
(A) The redox control system. Legend: proteins/protein variants in blue are constitutively expressed throughout the growth curve; proteins/protein variants in red are up-regulated at day 1 or 2 (logarithmic phase); proteins in purple are up-regulated in PNA^-^ choanomastigotes. (B) Summary of differential abundance of translation factors and enzymes involved in redox homeostasis throughout the growth curve and in the PNA^-^ subpopulation of choanomastigotes in stationary phase.](pone.0113837.g005){#pone-0113837-g005}

The analysis of the PNA^+^ and PNA^-^ subpopulations within the stationary phase has revealed that the entire redox defense system is up-regulated in the latter ([Table 3](#pone-0113837-t003){ref-type="table"}). This includes the catalase (three variants), the iron superoxide dismutase (Fe-SOD) (two variants), a hypothetical protein (CfaC1_05_0410) orthologue to the trypanothione reductases (TryR) of the pathogenic trypanosomatids and two TryP variants. Therefore, the thiol-based redox defense system is over-expressed in an NADPH-dependent manner in PNA^-^ choanomastigotes. These findings taken together with the expression profile observed throughout the growth curve suggest that the differentiation process of *C. fasciculata* motile choanomastigotes involves an increase in oxidative stress in the axenic culture model that is overcome by the up-regulation of this defense system. These changes have not been observed at the transcript level in *L. infantum* PNA^-^ promastigotes within the stationary phase [@pone.0113837-Alcolea1], as well as at the whole stationary phase population at the protein level in *L. infantum* [@pone.0113837-Alcolea2] and in *L. major* [@pone.0113837-Leifso1], [@pone.0113837-Levick1]. The Fe-SOD reduces the superoxide anions generated in the ribonucleotide reductase (RNR) reaction and other reactions to hydrogen peroxide. Then, the catalase and the TryP, catalyze hydrogen peroxide oxidation and peroxidative reactions (reviewed in [@pone.0113837-Day1]). The thiol-dependent mechanism also reinforces the reactive oxygen species (ROS) reduction ([Fig. 5](#pone-0113837-g005){ref-type="fig"}). This system was characterized in *C. fasciculata* and consists of the enzymes TryR and TryP, also including the tryparedoxin (TryX\[S\]/\[SH~2~\]). The trypanothione (T\[S\]/\[SH~2~\]) (reviewed in [@pone.0113837-Flohe1]). The T\[S\]/\[SH~2~\] consists of two glutathione residues coupled through a spermidine molecule. The peroxiredoxin TryP acts as a catalase and also reducing a variety of other ROS and the TryR regenerates the T\[SH~2~\] (reduced form) to T\[S\] (oxidized form).

To summarize, the thiol-based redox control system is over-expressed in mid logarithmic phase *C. fasciculata* choanomastigotes and at the PNA^-^ subpopulation within the stationary phase. The faster growth kinetics compared to *Leishmania* spp. may be related to the higher levels of oxidative stress overcome by the up-regulation of TDR1, TryP and the catalase in *C. fasciculata* rather than in *Leishmania* spp. The up-regulation of the TryR-TryP system together with the catalase and the Fe-SOD in PNA^-^ choanomastigotes suggests a relationship between differentiation and the capability to overcome increased levels of oxidative stress.

Differences in the proteome profiles of the motile stages of *C. fasciculata* and *Leishmania* spp {#s3g}
--------------------------------------------------------------------------------------------------

Stage-specific regulation at the transcript and protein levels in the genus *Leishmania* has been widely studied. Much of the information extracted is related to differentially regulated genes between amastigotes and promastigotes [@pone.0113837-Rosenzweig1], [@pone.0113837-Alcolea4], [@pone.0113837-Leifso1], [@pone.0113837-Holzer1], [@pone.0113837-Depledge1] but few analyses have provided data about differential expression throughout the promastigote growth curve [@pone.0113837-Saxena1], [@pone.0113837-Akopyants1], [@pone.0113837-Almeida1]. A high-throughput transcriptome analysis was specifically focused on the differences between logarithmic and stationary phase promastigotes with amastigotes in *L. infantum* [@pone.0113837-Alcolea3]. Comparing the proteomic data sets available for the motile stages of *L. infantum* [@pone.0113837-Alcolea2] and *C. fasciculata* (this work), an important difference has been found, the up-regulation of the TryR in logarithmic phase promastigotes in the former (this gene was reported as thiol-dependent antioxidant protein, gi21307665 in the NCBI protein databank and corresponds to gene LinJ.05.0350) *vs.* the PNA^-^ subpopulation in *C. fasciculata*.

Important differences with *Leishmania* spp. can be noticed taking the information extracted from the transcriptome and the proteome as a whole. Indeed, regarding metabolic processes, the expression profiles of glucolytic enzymes and the thiolase between the motile stages of *L. infantum* and *C. fasciculata* are different. Glucolysis is active in *Leishmania* spp. promastigotes and probably reaches its highest activity in stationary phase, whereas expression of many of the glucolytic enzymes decays in stationary phase choanomastigotes in *C. fasciculata*, being increased only in PNA^-^ parasites.

As a difference with the *L. major* TryP [@pone.0113837-Tetaud1], the *C. fasciculata* orthologue does not maintain constant expression levels in the motile stage, especially in the PNA^-^ subpopulation of choanomastigotes in stationary phase, where the whole thiol-based redox defense system (catalase, Fe-SOD, TryP, TryR) is up-regulated. In fact, differential expression of the TryR, the TryP and the Fe-SOD was not found in *L. major* and *L. infantum* metacyclic promastigotes, whereas the tryparedoxin levels vary between procyclic and metacyclic promastigotes in both species [@pone.0113837-Alcolea1], [@pone.0113837-Saxena1], [@pone.0113837-Akopyants1]. Additionally, up-regulation of the TryR observed in *L. infantum* logarithmic phase promastigotes has been precisely the only one not found in *C. fasciculata* choanomastigotes, where TDR1 is more abundant instead. The oxidative phase of the pentose-phosphate shunt is the source of NADPH for these important cellular processes and it is constitutively expressed in both organisms probably. However, the non-oxidative phase of this pathway is over-expressed in logarithmic phase only in *C. fasciculata*. The plethora of changes in gene expression regulation and post-translational modification of proteins observed previously in *L. infantum* promastigotes has not been observed in *C. fasciculata* choanomastigotes. Indeed, only the eIF5a, the EF1β, the EF2 and the hsp60 are up-regulated in logarithmic phase choanomastigotes ([Table 1](#pone-0113837-t001){ref-type="table"}) whereas the PABP, two RNAbp, two variants of the EF1α, an ATP-dependent RNA helicase, a different hsp60 variant, the Nkdb, a DnaJ chaperone and a peptidyl-prolyl cis-trans isomerase and two cyclophilins are constitutively expressed throughout the growth curve ([Table 2](#pone-0113837-t002){ref-type="table"}) according to this analysis. A different profile of EF2 expression was observed in *L. major*, where it is over-expressed in metacyclic promastigotes [@pone.0113837-Saxena1]. Interestingly, the EF1α is more abundant in PNA^-^ choanomastigotes of *C. fasciculata*, what is opposite to PNA^-^ promastigotes of *L. infantum*, where it decreases. This may be linked with differences between the developmental processes these parasites undergo instead of being related to growth in a rich medium and contributes to explain in part the differences between the life cycles of *C. fasciculata* and *Leishmania* spp. Promastigotes undergo a deep differentiation process inside the gut of the phlebotomine sand fly to successfully establish intracellular infection in the mammalian host. By contrast, the life cycle of *Crithidia* spp. is monogenetic and differentiation of the characteristic choanomastigote motile stage is probably not so complex because the amastigote stage is not intracellular. This assumption is suggested by the substantial differences found in the abundance of proteins involved in gene expression regulation and protein modification between both genera. However, both organisms are close in the crown of the phylogenetic tree of trypanosomatids and growth kinetics of their motile stages in culture is similar. For this reason, future in depth study of these differences in protein abundance may help to explain their different mechanisms of adaptation to axenic cultures that mimic the conditions of the insect host gut. The MASCOT identifications performed against the *NCBInr* database (Tables S1-S3 in [S1 File](#pone.0113837.s001){ref-type="supplementary-material"}) provide additional evidence for the hypothesis of a very close relationship in the evolutionary tree. The increased abundance of the translation factors eIF5a, EF1β the EF2 in early logarithmic phase choanomastigotes may be linked to a more active metabolic status required for growth, whereas the increase in eIF5a, EF1α and EF2 in the PNA^-^ choanomastigote subpopulation in stationary phase suggests a role in development, as it cannot be associated to growth under starvation conditions ([Fig. 5B](#pone-0113837-g005){ref-type="fig"}). The same has been observed with the redox homeostasis control system. Logarithmic phase *C. fasciculata* choanomastigotes up-regulate the ascorbate-dependent TDR1, as well as the TryP, the catalase and the Fe-SOD, probably because of an increased oxidative stress resulting from faster growth kinetics than in *Leishmania* spp., and the abundance of these enzymes decay in the ongoing of the growth curve. Then, it increases again in the PNA^-^ subpopulation within the stationary phase (TryR instead of TDR1), being presumably associated to development at this stage as well ([Fig. 5B](#pone-0113837-g005){ref-type="fig"}). It is important to notice that the expression profiles described correspond to the motile stages of these parasites in axenic culture and the developmental processes of *Crithidia* spp. are almost unexplored. The axenic culture model is widely accepted in *Leishmania* spp. because cultured promastigotes are able to stablish infection in mammalian hosts, what suggests that the main developmental processes may be reproduced in culture. In the case of *Crithidia* spp., it is not known whether culture greatly affects development. The main findings of this study point to similar but faster growth kinetics in *C. fasciculata* and different metabolic adaptations to the same culture medium conditions.

Conclusions {#s4}
===========

The growth kinetics is slightly faster in *C. fasciculata* than in *Leishmania* spp. Choanomastigotes of *C. fasciculata* are able to agglutinate with PNA and a non-agglutinating subpopulation can be isolated. Consequently, the behavior in the presence of the lectin is the same. Logarithmic phase choanomastigotes of *C. fasciculata* over-express CACK, enzymes involved in redox homeostasis (TDR1, TryP, catalase and Fe-SOD), the translation factors eIF5a, EF1β and EF2 and most of the glycolytic enzymes catalyzing irreversible reactions and the enzymes of the non-oxidative phase of the pentose-phosphate pathway. The abundance of the translation factors (EF1α instead of EF1β) and of the enzymes involved in redox homeostasis (TryR instead of TDR1) increases again in the PNA^-^ subpopulation. These changes in abundance may have a role in growth in the nutrient rich environment at the logarithmic phase and a role in differentiation in the minor PNA^-^ subpopulation within the population in stationary phase.
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**Supporting tables.** Table S1. Differentially regulated proteins throughout the growth curve of *C. fasciculata* choanomastigotes identified with the *NCBInr* database. Estimated pI, significant MASCOT scores and ratios to day 1 are provided. Only spots with statistically significant ratios (p\<0.05) over 1.7 or under 0.6 were picked and analyzed and are shown in the table. As a consequence, hyphens in the columns containing ratios do not necessarily indicate lack of differential abundance, because there are also cases of lack of statistical significance of ratios indicating over- or under-expression. Table S2. Constantly expressed proteins throughout the growth curve of *C. fasciculata* choanomastigotes identified with the *NCBInr* database. Estimated molecular weights, pI and significant MASCOT scores are provided. Table S3. Differential abundance of identified proteins between the PNA^+^ and PNA^-^ subpopulations of *C. fasciculata* choanomastigotes in stationary phase of axenic culture identified with the *NCBInr* database. Estimated molecular weights, pI, significant MASCOT scores and PNA^+^/PNA^-^ ratios. Only spots with statistically significant ratios (p\<0.05) over 1.7 or under 0.6 were picked and analyzed and are shown in the table.
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**Supporting figures.** Figure S1. Western blot of *C. fasciculata* choanomastigote protein extracts throughout the growth curve for CACK detection. Complete image of the autoradiography. Figure S2. Western blot of *C. fasciculata* choanomastigote protein extracts throughout the growth curve for gGAPDH detection. Complete image of the autoradiography.
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